Mouse transcriptome reveals potential signatures of protection and pathogenesis in human tuberculosis
暂无分享,去创建一个
A. Sher | P. Chakravarty | A. Singhania | A. O’Garra | M. Saraiva | P. S. Redford | P. Haldar | E. Stavropoulos | K. Mayer-Barber | S. Priestnall | Olivier Tabone | A. Suárez-Bonnet | C. Graham | Lúcia Moreira-Teixeira | Eleanor Herbert | K. L. Fonseca | J. Sousa | Baltazar Cá | R. Verma | A. Suárez‐Bonnet
[1] N. Mukaida,et al. Type I interferon-driven susceptibility to Mycobacterium tuberculosis is mediated by interleukin-1 receptor antagonist IL-1Ra , 2019, Nature Microbiology.
[2] Randle Aaron M. Villanueva,et al. ggplot2: Elegant Graphics for Data Analysis (2nd ed.) , 2019, Measurement: Interdisciplinary Research and Perspectives.
[3] Jing-Wen Lin,et al. Transcriptional profiling unveils type I and II interferon networks in blood and tissues across diseases , 2019, Nature Communications.
[4] Benjamin M. C. Swift,et al. A novel high sensitivity bacteriophage-based assay identifies low level M. tuberculosis bacteraemia in immunocompetent patients with active and incipient TB. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] Jason D. Buenrostro,et al. The cis-Regulatory Atlas of the Mouse Immune System , 2019, Cell.
[6] K. Ley,et al. Neutrophils: New insights and open questions , 2018, Science Immunology.
[7] Mark M. Davis,et al. A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes , 2018, Nature.
[8] N. Mukaida,et al. Interleukin-1 receptor antagonist mediates type I interferon-driven susceptibility to Mycobacterium tuberculosis , 2018, bioRxiv.
[9] A. Sher,et al. Type I interferons in tuberculosis: Foe and occasionally friend , 2018, The Journal of experimental medicine.
[10] S. Horswell,et al. Complement pathway gene activation and rising circulating immune complexes characterize early disease in HIV-associated tuberculosis , 2018, Proceedings of the National Academy of Sciences.
[11] R. Wilkinson,et al. A modular transcriptional signature identifies phenotypic heterogeneity of human tuberculosis infection , 2017, bioRxiv.
[12] John L. Johnson,et al. Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease , 2017, PLoS pathogens.
[13] H. Mollenkopf,et al. Concordant and discordant gene expression patterns in mouse strains identify best-fit animal model for human tuberculosis , 2017, Scientific Reports.
[14] C. Weaver,et al. T Cell–Derived IL-10 Impairs Host Resistance to Mycobacterium tuberculosis Infection , 2017, The Journal of Immunology.
[15] T. Jiang,et al. Inference of immune cell composition on the expression profiles of mouse tissue , 2017, Scientific Reports.
[16] V. Pascual,et al. The Transcriptional Signature of Active Tuberculosis Reflects Symptom Status in Extra-Pulmonary and Pulmonary Tuberculosis , 2016, PloS one.
[17] D. Lauffenburger,et al. A Functional Role for Antibodies in Tuberculosis , 2016, Cell.
[18] Måns Magnusson,et al. MultiQC: summarize analysis results for multiple tools and samples in a single report , 2016, Bioinform..
[19] Daniel E. Zak,et al. A prospective blood RNA signature for tuberculosis disease risk , 2016, The Lancet.
[20] J. Banchereau,et al. A 380-gene meta-signature of active tuberculosis compared with healthy controls , 2016, European Respiratory Journal.
[21] G. Beamer,et al. Mouse models of human TB pathology: roles in the analysis of necrosis and the development of host-directed therapies , 2015, Seminars in Immunopathology.
[22] M. Gonzalez-Juarrero,et al. Presence of multiple lesion types with vastly different microenvironments in C3HeB/FeJ mice following aerosol infection with Mycobacterium tuberculosis , 2015, Disease Models & Mechanisms.
[23] Ash A. Alizadeh,et al. Robust enumeration of cell subsets from tissue expression profiles , 2015, Nature Methods.
[24] Steven L Salzberg,et al. HISAT: a fast spliced aligner with low memory requirements , 2015, Nature Methods.
[25] A. Casadevall,et al. B cells and antibodies in the defense against Mycobacterium tuberculosis infection , 2015, Immunological reviews.
[26] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[27] Paul Theodor Pyl,et al. HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.
[28] A. Sher,et al. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk , 2014, Nature.
[29] H. Mollenkopf,et al. Type I IFN signaling triggers immunopathology in tuberculosis-susceptible mice by modulating lung phagocyte dynamics , 2014, European journal of immunology.
[30] Björn Usadel,et al. Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..
[31] A. Sher,et al. Influenza A Virus Impairs Control of Mycobacterium tuberculosis Coinfection Through a Type I Interferon Receptor–Dependent Pathway , 2013, The Journal of infectious diseases.
[32] M. Selman,et al. S100A8/A9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosis. , 2013, American journal of respiratory and critical care medicine.
[33] Michael Levin,et al. Detection of Tuberculosis in HIV-Infected and -Uninfected African Adults Using Whole Blood RNA Expression Signatures: A Case-Control Study , 2013, PLoS medicine.
[34] T. Ottenhoff,et al. A Helicopter Perspective on TB Biomarkers: Pathway and Process Based Analysis of Gene Expression Data Provides New Insight into TB Pathogenesis , 2013, PloS one.
[35] D. Chaussabel,et al. TPL-2–ERK1/2 Signaling Promotes Host Resistance against Intracellular Bacterial Infection by Negative Regulation of Type I IFN Production , 2013, The Journal of Immunology.
[36] V. Pascual,et al. Transcriptional Blood Signatures Distinguish Pulmonary Tuberculosis, Pulmonary Sarcoidosis, Pneumonias and Lung Cancers , 2013, PloS one.
[37] J. Thakar,et al. Quantitative set analysis for gene expression: a method to quantify gene set differential expression including gene-gene correlations , 2013, Nucleic acids research.
[38] J. Pedrosa,et al. Mycobacterium tuberculosis Strains Are Differentially Recognized by TLRs with an Impact on the Immune Response , 2013, PloS one.
[39] S. Basu,et al. Is passive diagnosis enough? The impact of subclinical disease on diagnostic strategies for tuberculosis. , 2013, American journal of respiratory and critical care medicine.
[40] Robert J Wilkinson,et al. The immune response in tuberculosis. , 2013, Annual review of immunology.
[41] J. Casanova,et al. Mycobacterial Disease and Impaired IFN-γ Immunity in Humans with Inherited ISG15 Deficiency , 2012, Science.
[42] B. Nandi,et al. Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection , 2011, The Journal of experimental medicine.
[43] A. Sher,et al. Role of innate cytokines in mycobacterial infection , 2011, Mucosal Immunology.
[44] B. Nandi,et al. Regulation of Neutrophils by Interferon-\(\gamma\) Limits Lung Inflammation During Tuberculosis Infection , 2011 .
[45] D Repsilber,et al. Human gene expression profiles of susceptibility and resistance in tuberculosis , 2011, Genes and Immunity.
[46] S. Behar,et al. Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy? , 2010, Nature Reviews Microbiology.
[47] Virginia Pascual,et al. An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human Tuberculosis , 2010, Nature.
[48] A. Sher,et al. Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. , 2010, The Journal of clinical investigation.
[49] H. Mollenkopf,et al. The adaptor molecule CARD9 is essential for tuberculosis control , 2010, The Journal of experimental medicine.
[50] Sang-Nae Cho,et al. Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. , 2010, Chest.
[51] J. Flynn,et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies , 2009, Nature Reviews Microbiology.
[52] L. Kobzik,et al. Immunopathology and Infectious Diseases Dominant Role of the sst 1 Locus in Pathogenesis of Necrotizing Lung Granulomas during Chronic Tuberculosis Infection and Reactivation in Genetically Resistant Hosts , 2010 .
[53] Steve Horvath,et al. WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.
[54] D. Koller,et al. The Immunological Genome Project: networks of gene expression in immune cells , 2008, Nature Immunology.
[55] Bin Zhang,et al. Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R , 2008, Bioinform..
[56] I. Orme,et al. The Hypervirulent Mycobacterium tuberculosis Strain HN878 Induces a Potent TH1 Response followed by Rapid Down-Regulation1 , 2007, The Journal of Immunology.
[57] Andy M. Yip,et al. Gene network interconnectedness and the generalized topological overlap measure , 2007, BMC Bioinformatics.
[58] A. Sher,et al. NK Cell-Derived IFN-γ Differentially Regulates Innate Resistance and Neutrophil Response in T Cell-Deficient Hosts Infected with Mycobacterium tuberculosis , 2006, The Journal of Immunology.
[59] S. Ehlers,et al. Oxygen status of lung granulomas in Mycobacterium tuberculosis‐infected mice , 2006, The Journal of pathology.
[60] G. Kaplan,et al. Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[61] A. Apt,et al. Neutrophil Responses to Mycobacterium tuberculosis Infection in Genetically Susceptible and Resistant Mice , 2005, Infection and Immunity.
[62] J. Casanova,et al. Genetic dissection of immunity to mycobacteria: the human model. , 2002, Annual review of immunology.
[63] J. Flynn,et al. Immunology of tuberculosis. , 2003, Annual review of immunology.
[64] G. Kaplan,et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[65] S. Ehlers,et al. Expression of the Nitric Oxide Synthase 2 Gene Is Not Essential for Early Control of Mycobacterium tuberculosis in the Murine Lung , 2000, Infection and Immunity.
[66] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[67] C. Dolea,et al. World Health Organization , 1949, International Organization.